Beaulieu Joseph
Corporate Controller at Epizyme, Inc.
- Sold, on record
- $64k
- Dollars the filings state
- Form 4 sales
- 9
- Latest Feb 7, 2022
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Epizyme, Inc.Corporate Controller
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Epizyme, Inc.Plan not statedJan 24, 2020 2020
Sold 330 shares at $24.63 ($8k)
Beaulieu Joseph, Corporate Controller
Sold 24.1% of holdings ($34k position)1,042 shares leftFiling
- 2 Form 4 sale Epizyme, Inc.Plan not statedMar 3, 2020 +39 days
Sold 996 shares at $22.18 ($22k)
Beaulieu Joseph, Corporate Controller
Sold 21.6% of holdings ($102k position)3,617 shares leftFiling
- 3 Form 4 sale Epizyme, Inc.Plan not statedMar 25, 2020 +22 days
Sold 212 shares at $15.28 ($3k)
Beaulieu Joseph, Corporate Controller
Sold 4.1% of holdings ($79k position)4,961 shares left0.6x usual sizeFiling
- 4 Form 4 sale Epizyme, Inc.Plan not statedJun 26, 2020 +93 days
Sold 317 shares at $16.15 ($5k)
Beaulieu Joseph, Corporate Controller
Sold 6.1% of holdings ($83k position)4,838 shares left1.2x usual sizeFiling
- 5 Form 4 sale Epizyme, Inc.Plan not statedSep 2, 2020 +68 days
Sold 1,514 shares at $12.81 ($19k)
Beaulieu Joseph, Corporate Controller
Sold 20.3% of holdings ($96k position)5,958 shares leftFiling
- 6 Form 4 sale Epizyme, Inc.Plan not statedFeb 4, 2021 +155 days
Sold 227 shares at $11.21 ($3k)
Beaulieu Joseph, Corporate Controller
Sold 1.7% of holdings ($153k position)13,431 shares left0.7x usual sizeFiling
- 7 Form 4 sale Epizyme, Inc.Plan not statedFeb 2, 2022 +363 days
Sold 687 shares at $1.37 ($941)
Beaulieu Joseph, Corporate Controller
Sold 2.3% of holdings ($40k position)28,854 shares left2.5x usual sizeFiling
- 8 Form 4 sale Epizyme, Inc.Plan not statedFeb 7, 2022 +5 days
Sold 222 shares at $1.50 ($333)
Beaulieu Joseph, Corporate Controller
Sold 0.8% of holdings ($43k position)28,632 shares left0.7x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (9)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Feb 7, 2022 | Feb 9, 2022 | Epizyme, Inc. | Corporate Controller | Form 4 sale | 222 | $333 | 0.8% | Plan not stated | SEC |
| Feb 2, 2022 | Feb 4, 2022 | Epizyme, Inc. | Corporate Controller | Form 4 sale | 687 | $941 | 2.3% | Plan not stated | SEC |
| Feb 4, 2021 | Feb 5, 2021 | Epizyme, Inc. | Corporate Controller | Form 4 sale | 227 | $3k | 1.7% | Plan not stated | SEC |
| Sep 2, 2020 | Sep 3, 2020 | Epizyme, Inc. | Corporate Controller | Form 4 sale | 1,514 | $19k | 20.3% | Plan not stated | SEC |
| Jun 26, 2020 | Jun 30, 2020 | Epizyme, Inc. | Corporate Controller | Form 4 sale | 317 | $5k | 6.1% | Plan not stated | SEC |
| Mar 25, 2020 | Mar 26, 2020 | Epizyme, Inc. | Corporate Controller | Form 4 sale | 212 | $3k | 4.1% | Plan not stated | SEC |
| Mar 3, 2020 | Mar 5, 2020 | Epizyme, Inc. | Corporate Controller | Form 4 sale | 996 | $22k | 21.6% | Plan not stated | SEC |
| Jan 24, 2020 | Jan 27, 2020 | Epizyme, Inc. | Corporate Controller | Form 4 sale | 330 | $8k | 24.1% | Plan not stated | SEC |
| Jun 13, 2019 | Jun 14, 2019 | Epizyme, Inc. | Corporate Controller | Form 4 sale | 203 | $2k | 29.0% | Unusual | SEC |